CyrusOne Inc.
CyrusOne Inc. Fundamental Analysis
CyrusOne Inc. (CONE) shows weak financial fundamentals with a PE ratio of 442.51, profit margin of 2.10%, and ROE of 0.92%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 28.8/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze CONE's fundamental strength across five key dimensions:
Efficiency Score
WeakCONE struggles to generate sufficient returns from assets.
Valuation Score
WeakCONE trades at a premium to fair value.
Growth Score
ModerateCONE shows steady but slowing expansion.
Financial Health Score
ModerateCONE shows balanced financial health with some risks.
Profitability Score
WeakCONE struggles to sustain strong margins.
Key Financial Metrics
Is CONE Expensive or Cheap?
P/E Ratio
CONE trades at 442.51 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, CONE's PEG of 4.43 indicates potential overvaluation.
Price to Book
The market values CyrusOne Inc. at 3.83 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at -5.96 times EBITDA. This is generally considered low.
How Well Does CONE Make Money?
Net Profit Margin
For every $100 in sales, CyrusOne Inc. keeps $2.10 as profit after all expenses.
Operating Margin
Core operations generate 7.05 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $0.92 in profit for every $100 of shareholder equity.
ROA
CyrusOne Inc. generates $0.34 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
FCF Per Share
Each share generates $3.85 in free cash annually.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
442.51
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
4.43
vs 25 benchmark
P/B Ratio
Price to book value ratio
3.83
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.00
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
1.31
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.57
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.009
vs 25 benchmark
ROA
Return on assets percentage
0.003
vs 25 benchmark
ROCE
Return on capital employed
0.01
vs 25 benchmark
How CONE Stacks Against Its Sector Peers
| Metric | CONE Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 442.51 | 24.23 | Worse (Expensive) |
| ROE | 0.92% | 659.00% | Weak |
| Net Margin | 2.10% | 4497.00% | Weak |
| Debt/Equity | 1.31 | -22.14 (disorted) | Distorted |
| Current Ratio | 1.57 | 13.87 | Neutral |
| ROA | 0.34% | -1390.00% (disorted) | Weak |
CONE outperforms its industry in 0 out of 6 key metrics, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews CyrusOne Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Income, Inflation Hedge, REIT
EPS CAGR
N/A
Industry Style: Income, Inflation Hedge, REIT
FCF CAGR
N/A
Industry Style: Income, Inflation Hedge, REIT